Sfoglia per AUTORE
TABBò F
Collezione ASL Cuneo 2

  

Items : 4

Clinical and Molecular Traits of a Novel SPECC1L-ALK Fusion in a Patient with Advanced Non-Small Cell Lung Cancer. in Journal of personalized medicine / J Pers Med. 2024 Jun 21;14(7):670. doi: 10.3390/jpm14070670.
2024
ASL Cuneo 2
AOU San Luigi di Orbassano

Merlini A; Righi L; Tabbò F; Benso F; Di Micco CM; Fabrizio FP; Centra F; Castellana S; Petrizzelli F; Sparaneo A; Trombetta D; Mazza T; Centonza A; Graziano P; Muscarella LA;

Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA). in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2024 Dec 16:S1556-0864(24)02529-2. doi: 10.1016/j.jtho.2024.12.010.
2024
ASL Cuneo 2
ASL Asti
AOU San Luigi di Orbassano

Novello S; Scagliotti G; Righi L; Vallone S; Malapelle U; Volante M; Giannarelli D; Mohorcic K; Meoni G; Scotti V; Linardou H; Bettini AC; Ramizi KM; Secen N; Comanescu A; Felip E; Paz-Ares L; Pignataro D; Araujo A; Barbieri V; Mazilu L; Buffoni L; Taveggia PA; Simionato F; Roca E; Sini C; Tabbò F; Reale ML; Zambelli V; et alii...

Efficacy of alectinib in lung adenocarcinoma patients with different anaplastic lymphoma kinase (ALK) rearrangements and co-existing alterations-a retrospective cohort study. in Translational lung cancer research / Transl Lung Cancer Res. 2023 Dec 26;12(12):2505-2519. doi: 10.21037/tlcr-23-658. Epub 2023 Nov 22.
2023
ASL Cuneo 2

Li J; Huang K; Ji H; Qian J; Lu H; Zhang Y; Russo A; Romero A; Urbanska EM; Tabbò F; Zhao X; Chu T;

Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC. in Frontiers in oncology / Front Oncol. 2023 Jun 22;13:1239304. doi: 10.3389/fonc.2023.1239304. eCollection 2023.
2023
ASL Cuneo 2

Malapelle U; Tabbò F; Muscarella LA;